These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25704450)

  • 21. Epidemiology of whooping cough & typing of Bordetella pertussis.
    Hegerle N; Guiso N
    Future Microbiol; 2013 Nov; 8(11):1391-403. PubMed ID: 24199799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.
    Patel SS; Wagstaff AJ
    Drugs; 1996 Aug; 52(2):254-75. PubMed ID: 8841742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
    Syed MA; Ahmed W; Naeem A; Bokhari H
    J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of acellular pertussis vaccine in young infants.
    Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
    J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives.
    Cherry JD; Grimprel E; Guiso N; Heininger U; Mertsola J
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S25-34. PubMed ID: 15876920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of acellular diphtheria, pertussis and tetanus vaccines in southern Ghana.
    Afari EA; Kamiya Y; Nkrumah FK; Dunyo SK; Akpedonu P; Kamiya H; Fukai F
    Ann Trop Paediatr; 1996 Mar; 16(1):39-48. PubMed ID: 8787364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
    Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
    BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness.
    Kenyon TA; Izurieta H; Shulman ST; Rosenfeld E; Miller M; Daum R; Strebel PM
    Pediatr Infect Dis J; 1996 Aug; 15(8):655-61. PubMed ID: 8858667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. As immunity wanes, whooping cough returns.
    Chin TL
    Health Aff (Millwood); 2014 Dec; 33(12):2095-8. PubMed ID: 25489026
    [No Abstract]   [Full Text] [Related]  

  • 30. [Genetic variability of Bordetella pertussis strains. Part II. Perspectives].
    Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
    Przegl Epidemiol; 2003; 57(1):193-200. PubMed ID: 12926328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis.
    Parton R; Hall E; Wardlaw AC
    J Med Microbiol; 1994 May; 40(5):307-12. PubMed ID: 8176718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bordetella pertussis: current aspects and future prospects in public health].
    Martínez Pérez E
    An R Acad Nac Med (Madr); 1993; 110(1):105-24; discussion 125. PubMed ID: 8238816
    [No Abstract]   [Full Text] [Related]  

  • 35. Pertussis Outbreak in Infants and an Immunization Campaign Based on Providing Pertussis Vaccine Doses at 6 Weeks, 10 Weeks, and 14 Weeks.
    Stein-Zamir C; Sokolov I; Abramson N; Shoob H
    Pediatr Infect Dis J; 2019 Mar; 38(3):e63-e64. PubMed ID: 30762709
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype.
    Advani A; Gustafsson L; Carlsson RM; Donnelly D; Hallander HO
    APMIS; 2007 Jun; 115(6):736-42. PubMed ID: 17550382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations.
    Hethcote HW
    Math Biosci; 1999 Apr; 158(1):47-73. PubMed ID: 10209936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
    Zamir CS; Dahan DB; Shoob H
    Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe.
    Levine OS; Lagos R; Losonsky GA; San Martin O; Abrego P; Bustamante C; Wasserman SS; Levine MM
    J Infect Dis; 1996 Dec; 174(6):1341-4. PubMed ID: 8940230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.